Qsemble Capital Management, LP Abb Vie Inc. Transaction History

Qsemble Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $4.76 Million - $5.42 Million	29,762 New	29,762 $5.42 Billion
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $120,231 - $139,185	900 Added 7.38%	13,100 $1.95 Billion
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $1.62 Million - $2.01 Million	12,200 New	12,200 $1.64 Billion
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $691,550 - $829,350	5,000 New	5,000 $808 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Qsemble Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Qsemble Capital Management, LP with notifications on news.